Published in Am J Transplant on February 25, 2010
The therapeutic potential of carbon monoxide. Nat Rev Drug Discov (2010) 3.03
Contribution of large pig for renal ischemia-reperfusion and transplantation studies: the preclinical model. J Biomed Biotechnol (2011) 1.26
The social network of carbon monoxide in medicine. Trends Mol Med (2012) 1.05
Heme oxygenase system in hepatic ischemia-reperfusion injury. World J Gastroenterol (2010) 0.94
Targeting heme oxygenase-1 and carbon monoxide for therapeutic modulation of inflammation. Transl Res (2015) 0.90
Emergent role of gasotransmitters in ischemia-reperfusion injury. Med Gas Res (2011) 0.89
The role of innate immunity in donor organ procurement. Semin Immunopathol (2011) 0.83
CO and CO-releasing molecules (CO-RMs) in acute gastrointestinal inflammation. Br J Pharmacol (2014) 0.82
Testing Danegaptide Effects on Kidney Function after Ischemia/Reperfusion Injury in a New Porcine Two Week Model. PLoS One (2016) 0.77
Functional evaluation of rat hearts transplanted after preservation in a high-pressure gaseous mixture of carbon monoxide and oxygen. Sci Rep (2016) 0.77
Use of carbon monoxide in minimizing ischemia/reperfusion injury in transplantation. Transplant Rev (Orlando) (2011) 0.77
Characteristics of exogenous carbon monoxide deliveries. Med Gas Res (2016) 0.75
High-pressure carbon monoxide preserves rat kidney grafts from apoptosis and inflammation. Lab Invest (2017) 0.75
Significance of the carboxyhemoglobin level for out-of-hospital cardiopulmonary arrest. J Emerg Trauma Shock (2012) 0.75
The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci U S A (1968) 6.96
Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med (2000) 6.32
Carbon monoxide: a putative neural messenger. Science (1993) 5.47
Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J Exp Med (2000) 3.41
Use of single voided urine samples to estimate quantitative proteinuria. N Engl J Med (1983) 3.32
Delayed graft function in kidney transplantation. Lancet (2004) 3.06
Soluble guanylate cyclase from bovine lung: activation with nitric oxide and carbon monoxide and spectral characterization of the ferrous and ferric states. Biochemistry (1994) 2.65
Paradoxical rescue from ischemic lung injury by inhaled carbon monoxide driven by derepression of fibrinolysis. Nat Med (2001) 2.62
Relative quantification of mRNA: comparison of methods currently used for real-time PCR data analysis. BMC Mol Biol (2007) 2.31
Use of protein:creatinine ratio measurements on random urine samples for prediction of significant proteinuria: a systematic review. Clin Chem (2005) 1.89
Apocynin attenuates tubular apoptosis and tubulointerstitial fibrosis in transgenic mice independent of hypertension. Kidney Int (2008) 1.78
Carbon monoxide signals via inhibition of cytochrome c oxidase and generation of mitochondrial reactive oxygen species. FASEB J (2007) 1.60
Carbon monoxide: an endogenous modulator of sinusoidal tone in the perfused rat liver. J Clin Invest (1995) 1.41
Protection of transplant-induced renal ischemia-reperfusion injury with carbon monoxide. Am J Physiol Renal Physiol (2004) 1.33
Delayed graft function in renal transplantation: etiology, management and long-term significance. J Urol (1996) 1.28
Ex vivo carbon monoxide prevents cytochrome P450 degradation and ischemia/reperfusion injury of kidney grafts. Kidney Int (2008) 1.09
Treatment with CO-RMs during cold storage improves renal function at reperfusion. Kidney Int (2006) 1.07
Cellular and molecular predictors of chronic renal dysfunction after initial ischemia/reperfusion injury of a single kidney. Transplantation (1997) 1.07
Carbon monoxide ameliorates renal cold ischemia-reperfusion injury with an upregulation of vascular endothelial growth factor by activation of hypoxia-inducible factor. Transplantation (2008) 1.05
Ex vivo application of carbon monoxide in University of Wisconsin solution to prevent intestinal cold ischemia/reperfusion injury. Am J Transplant (2006) 0.99
A comparison of renal preservation by cold storage and machine perfusion using a porcine autotransplant model. Transplantation (2004) 0.93
Long-term kidney isografts develop functional and morphologic changes that mimic those of chronic allograft rejection. Ann Surg (1994) 0.93
Patterns of cellular gene expression in swine macrophages infected with highly virulent classical swine fever virus strain Brescia. Virus Res (2008) 0.91
Liver graft exposure to carbon monoxide during cold storage protects sinusoidal endothelial cells and ameliorates reperfusion injury in rats. Liver Transpl (2009) 0.91
Improved myocardial function after cold storage with preservation solution supplemented with a carbon monoxide-releasing molecule (CORM-3). J Heart Lung Transplant (2007) 0.90
Improved kidney graft function after preservation using a novel hypothermic machine perfusion device. Ann Surg (2007) 0.89
Trimetazidine reduces renal dysfunction by limiting the cold ischemia/reperfusion injury in autotransplanted pig kidneys. J Am Soc Nephrol (2000) 0.88
Protective roles of polyethylene glycol and trimetazidine against cold ischemia and reperfusion injuries of pig kidney graft. Am J Transplant (2004) 0.87
A modified University of Wisconsin preservation solution with high-NA+ low-K+ content reduces reperfusion injury of the pig kidney graft. Transplantation (2003) 0.86
Carbon monoxide protects against ischemia-reperfusion injury in an experimental model of controlled nonheartbeating donor kidney. Transplantation (2008) 0.86
Parameters of humoral and cellular immunity following vaccination of pigs with a European modified-live strain of porcine reproductive and respiratory syndrome virus (PRRSV). Viral Immunol (2003) 0.84
Carbon monoxide mediates vasoactive intestinal polypeptide-associated nonadrenergic/noncholinergic neurotransmission. Proc Natl Acad Sci U S A (2004) 0.83
Application of nitric oxide and carbon monoxide in a model of renal preservation. Br J Surg (2008) 0.80
Kidney preservation in pigs using celsior, a new organ preservation solution. Transplant Proc (1997) 0.79
Improved porcine renal preservation with a simple extracellular solution--PBS140. Transplantation (1991) 0.77
Cell migration, chimerism, and graft acceptance. Lancet (1992) 12.24
Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology (1993) 8.76
Bone marrow as a potential source of hepatic oval cells. Science (1999) 8.52
Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74
Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet (1984) 4.49
Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32
Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation. Immunol Today (1993) 4.29
Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. Transplant Proc (1987) 4.21
Systemic chimerism in human female recipients of male livers. Lancet (1992) 3.63
Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease. N Engl J Med (1993) 3.36
The lost chord: microchimerism and allograft survival. Immunol Today (1996) 2.81
Hematolymphoid cell trafficking, microchimerism, and GVH reactions after liver, bone marrow, and heart transplantation. Transplant Proc (1993) 2.81
Cadaveric small bowel and small bowel-liver transplantation in humans. Transplantation (1992) 2.75
THE IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 IN RATS RECEIVING HETEROTOPIC CARDIAC ALLOGRAFTS. Surg Res Commun (1987) 2.75
Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production. J Immunol (1994) 2.68
Nutritional predictors of postoperative outcome in pancreatic cancer. Br J Surg (2011) 2.57
Emergency department revisits. Ann Emerg Med (1989) 2.55
Cross-talk between epidermal growth factor receptor and c-Met signal pathways in transformed cells. J Biol Chem (2000) 2.46
Toxicology of FK-506 in the Lewis rat. Transplant Proc (1987) 2.37
Clinical intestinal transplantation: new perspectives and immunologic considerations. J Am Coll Surg (1998) 2.31
Carcinoma of the male breast. Ann Intern Med (1992) 2.27
Treatment of fibrolamellar hepatoma with partial or total hepatectomy and transplantation of the liver. Surg Gynecol Obstet (1986) 2.07
Phospholipase D and its product, phosphatidic acid, mediate agonist-dependent raf-1 translocation to the plasma membrane and the activation of the mitogen-activated protein kinase pathway. J Biol Chem (1999) 2.02
Analgesic effect of morphine glucuronides. Tohoku J Exp Med (1971) 2.02
Hydroporation as the mechanism of hydrodynamic delivery. Gene Ther (2004) 1.97
Successful hamster-to-rat liver xenotransplantation under FK506 immunosuppression induces unresponsiveness to hamster heart and skin. Transplantation (1993) 1.94
Protective roles of mast cells against enterobacterial infection are mediated by Toll-like receptor 4. J Immunol (2001) 1.90
Hydrogen inhalation ameliorates oxidative stress in transplantation induced intestinal graft injury. Am J Transplant (2008) 1.86
Identification of bipotential progenitor cells in human liver development. Hepatology (1996) 1.84
A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer. Br J Cancer (2009) 1.84
Microchimerism, dendritic cell progenitors and transplantation tolerance. Stem Cells (1995) 1.83
Extracellular matrix remodeling at the early stages of liver regeneration in the rat. Hepatology (1997) 1.79
Early events in liver allograft rejection. Delineation of sites of simultaneous intragraft and recipient lymphoid tissue sensitization. Am J Pathol (1991) 1.78
The detection of TP53 mutations in chronic lymphocytic leukemia independently predicts rapid disease progression and is highly correlated with a complex aberrant karyotype. Leukemia (2008) 1.76
Prolonged administration of sex hormones to castrated rats. Biochem J (1939) 1.76
Co-culturing human prostate carcinoma cells with hepatocytes leads to increased expression of E-cadherin. Br J Cancer (2007) 1.75
The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantation (1988) 1.72
Oxidative and nitrosative stress in acute renal ischemia. Am J Physiol Renal Physiol (2001) 1.71
Changes in WNT/beta-catenin pathway during regulated growth in rat liver regeneration. Hepatology (2001) 1.71
Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting. Transplantation (1999) 1.70
Long-term controlled normoglycemia in diabetic non-human primates after transplantation with hCD46 transgenic porcine islets. Am J Transplant (2009) 1.69
Psychogenic seizures: ictal characteristics and diagnostic pitfalls. Neurology (1992) 1.68
Mitosis and apoptosis in the liver of interleukin-6-deficient mice after partial hepatectomy. Hepatology (1999) 1.64
Significance of Aspergillus species isolated from respiratory secretions in the diagnosis of invasive pulmonary aspergillosis. J Clin Microbiol (1980) 1.64
A microscale in vitro physiological model of the liver: predictive screens for drug metabolism and enzyme induction. Curr Drug Metab (2005) 1.61
Donor dendritic cells after liver and heart allotransplantation under short-term immunosuppression. Lancet (1992) 1.61
Defects in pulmonary vasculature and perinatal lung hemorrhage in mice heterozygous null for the Forkhead Box f1 transcription factor. Dev Biol (2001) 1.59
Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: a distinct entity? Am J Surg Pathol (2000) 1.56
The biological basis of and strategies for clinical xenotransplantation. Immunol Rev (1994) 1.56
Sinusoidal ultrastructure evaluated during the revascularization of regenerating rat liver. Hepatology (2001) 1.55
Impact on the care of the emergency department chest pain patient from the chest pain evaluation registry (CHEPER) study. Am J Cardiol (1997) 1.54
Immunomodulation for intestinal transplantation by allograft irradiation, adjunct donor bone marrow infusion, or both. Transplantation (2000) 1.53
Morphological monitoring of human small bowel allografts. Transplant Proc (1993) 1.52
Drug development and testing in relation to cell migration and chimerism. Transplant Proc (1993) 1.52
A clinicopathological study of human liver allograft recipients harboring preformed IgG lymphocytotoxic antibodies. Hepatology (1992) 1.50
Expression and activation of pro-MMP-2 and pro-MMP-9 during rat liver regeneration. Hepatology (2000) 1.50
Noninvasive measures of oxidative metabolism on working human muscles by near-infrared spectroscopy. J Appl Physiol (1985) (1996) 1.50
The effect of FK-506 on hyperacute rejection in presensitized rats. Transplant Proc (1987) 1.49
Dynamic changes in the characteristics of cationic lipidic vectors after exposure to mouse serum: implications for intravenous lipofection. Gene Ther (1999) 1.47
Antioxidant supplementation decreases oxidative DNA damage in human lymphocytes. Cancer Res (1996) 1.46
The effects of gamma-glutamylcysteine ethyl ester, a prodrug of glutathione, on ischemia-reperfusion-induced liver injury in rats. Transplantation (1992) 1.46
Hamster to rat kidney xenotransplantation. Effects of FK 506, cyclophosphamide, organ perfusion, and complement inhibition. Transplantation (1995) 1.45
Clinical intestinal transplantation: a decade of experience at a single center. Ann Surg (2001) 1.44
Kinematically specific interhemispheric inhibition operating in the process of generation of a voluntary movement. Cereb Cortex (2004) 1.43
Spatiotemporal expression of angiogenesis growth factor receptors during the revascularization of regenerating rat liver. Hepatology (2001) 1.42
Pretransplant pharmacodynamic analysis of immunosuppressive agents using CFSE-based T-cell proliferation assay. Clin Pharmacol Ther (2009) 1.42
Analysis of chronic rejection and obliterative arteriopathy. Possible contributions of donor antigen-presenting cells and lymphatic disruption. Am J Pathol (1997) 1.41
The expression profile of C19MC microRNAs in primary human trophoblast cells and exosomes. Mol Hum Reprod (2012) 1.41
Differential inhibition of Smad6 and Smad7 on bone morphogenetic protein- and activin-mediated growth arrest and apoptosis in B cells. J Biol Chem (1999) 1.41
Structural impact of hydrodynamic injection on mouse liver. Gene Ther (2006) 1.41
Cancer and Race. Can Med Assoc J (1926) 1.39
Fatty acid metabolism in neurodevelopmental disorder: a new perspective on associations between attention-deficit/hyperactivity disorder, dyslexia, dyspraxia and the autistic spectrum. Prostaglandins Leukot Essent Fatty Acids (2000) 1.39
Characterization of intracellular signals via tyrosine 1062 in RET activated by glial cell line-derived neurotrophic factor. Oncogene (2000) 1.37
The prognosis of intraductal papillary mucinous tumors of the pancreas. Hepatogastroenterology (2001) 1.37
Hypermethylation of multiple genes as clonal markers in multicentric hepatocellular carcinoma. Br J Cancer (2007) 1.35
Hepatocyte paraffin 1: a monoclonal antibody that reacts with hepatocytes and can be used for differential diagnosis of hepatic tumors. Am J Pathol (1993) 1.33
A fresh look at augmenter of liver regeneration in rats. Hepatology (1999) 1.32
Donor dendritic cell repopulation in recipients after rat-to-mouse bone-marrow transplantation. Lancet (1992) 1.32
Effect of FK506 in experimental organ transplantation. Transplant Proc (1988) 1.32
Sensitivity of activated human lymphocytes to cyclosporine and its metabolites. Hum Immunol (1988) 1.31
The development and compensation of biliary cirrhosis in interleukin-6-deficient mice. Am J Pathol (2000) 1.31
Histological organization in hepatocyte organoid cultures. Am J Pathol (2001) 1.31
Impact of thrombocytopenia on survival of baboons with genetically modified pig liver transplants: clinical relevance. Am J Transplant (2009) 1.29
Elevated levels of hepatocyte nuclear factor 3beta in mouse hepatocytes influence expression of genes involved in bile acid and glucose homeostasis. Mol Cell Biol (2000) 1.29
Influence of various hemodialysis membranes on the plasma (1-->3)-beta-D-glucan level. Kidney Int (2001) 1.29
Spontaneous and iatrogenically augmented leukocyte chimerism in organ transplant recipients. Transplant Proc (1994) 1.29
The effect of FK 506 and CyA on the Lewis rat renal ischemia model. Transplant Proc (1990) 1.28
Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data. Transplantation (1998) 1.28
Endoscopic gastric submucosal transplantation of islets (ENDO-STI): technique and initial results in diabetic pigs. Am J Transplant (2009) 1.27
Identification of bipotential progenitor cells in human liver regeneration. Lab Invest (1996) 1.26
Cancer immunotherapy of established tumors with IL-12. Effective delivery by genetically engineered fibroblasts. J Immunol (1995) 1.25
EPR detection of heme and nonheme iron-containing protein nitrosylation by nitric oxide during rejection of rat heart allograft. J Biol Chem (1992) 1.24
Physical and functional interaction of murine and Xenopus Smad7 with bone morphogenetic protein receptors and transforming growth factor-beta receptors. J Biol Chem (1998) 1.23
Correlation between copy number of mitochondrial DNA and clinico-pathologic parameters of hepatocellular carcinoma. Eur J Surg Oncol (2006) 1.23